Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2002
10/03/2002WO2002059127A3 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists
10/03/2002US20020143185 Nitrosation process
10/03/2002US20020143175 Reacting the corresponding pyrrole and aldehyde in a solvent free system under microwave radiation in the presence of a zeolite molecular sieve catalyst to obtain tetraaryl porphyrin
10/03/2002US20020143035 Hydantoin compounds useful as anti-inflammatory agents
10/03/2002US20020143024 As antihypertensive agents; for therapy of disorders related to renal, glomerular and mesangial cell function; therapy of endotoxemia or endotoxin shock as well as hemorrhagic shock; useful in alleviation of pain associated cancer
10/03/2002US20020143016 Administering to a patient suffering from anxiety a therapeutically or prophylactically effective amount of N-desmethylzopiclone, or a pharmaceutically acceptable salt, solvate, hydrate, or clathrate
10/03/2002US20020143015 Use of vardenafil or pharmaceutically or veterinarily acceptable salt, or solvate in preparation of a medicament for curative, palliative or prophylactic therapy of type 2 diabetes mellitus
10/03/2002US20020143008 CRF receptor antagonists and methods relating thereto
10/03/2002US20020143006 Process for production of optically active pyrroloazepine derivatives
10/03/2002US20020142968 For therapeutic and/or prophylactic treatment of idiopathic and adult respiratory distress syndrome, pulmonary fibrosis following treatment with radiation or chemotherapy, septic shock, septicemia, inflammatory responses
10/03/2002CA2442573A1 Process for the preparation of benazepril
10/03/2002CA2441926A1 (oxo-pyrazolo[1,5a]pyrimidin-2-yl)alkyl-carboxamides
10/03/2002CA2441455A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
10/03/2002CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002CA2439676A1 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
10/02/2002EP1244679A1 Purine derivatives
10/02/2002EP1244674A2 Microbicidal effect of porphyrines in darkness
10/02/2002EP1244673A2 Novel imidazo 1,3,5]triazinones and the use thereof
10/02/2002EP1244672A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
10/02/2002EP1244671A1 Triazolo-pyrimidine derivatives as ligands for gaba receptors
10/02/2002EP1244670A1 Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
10/02/2002EP1244669A1 Pyrazolopyrazines and their use as adenosine antagonists
10/02/2002EP1244664A1 Compounds and methods for the treatment of pain
10/02/2002EP1244660A1 Methods and compositions for the treatment of pain
10/02/2002EP1244658A2 Azolyl-alkyl azole derivatives, a method for their production and their use as pesticides
10/02/2002EP1244453A1 Method and composition for the treatment of pain
10/02/2002EP1129091B1 Crf receptor antagonists and methods relating thereto
10/02/2002EP0804196B1 Use of serotonin antagonists (5ht 3) for treating fibromyalgia
10/02/2002EP0706521B1 Imides as tnf alpha inhibitors
10/02/2002DE10115921A1 Verfahren zur Herstellung von 4,6-Diaminopyrimido[5,4-d]pyrimidinen Process for the preparation of 4,6-Diaminopyrimido [5,4-d] pyrimidines
10/02/2002CN1372562A Imidazoimidazoles and triazoles as anti-inflammatory agents
10/02/2002CN1372561A Synthese of substitutd pyrazolopyrimidines
10/02/2002CN1372546A Fused pyrrolecarboxamides GABA brain receptor ligands
10/01/2002US6458986 Intermediate for (R)-3-(4-Bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-H-imidazo[1,2-α]imidazol-2-one
10/01/2002US6458951 For treatment of male erectile dysfunction, female sexual dysfunction
10/01/2002US6458830 The compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis and postherpetic neuralgia.
10/01/2002US6458825 Eukaryotic cells contain multiple proteolytic systems, including lysosomal proteases, calpains, atp-ubiquitin-proteasome dependent pathway, and an
10/01/2002US6458800 1,2-annelated quinoline derivatives
10/01/2002US6458796 Method of treating cardiovascular disorders, thromboembolic disorders and ischaemias, and urogenital system disorders, comprising administering to mammals
10/01/2002US6458792 Medicament for the treatment of inflammatory, immunological, bronchopulmonary, cardiovascular, oncological or cns-degenerative disorders.
10/01/2002US6458791 Methods of treating muscle spasms using N-desmethylzopiclone
10/01/2002US6458790 Substituted piperidines as melanocortin receptor agonists
10/01/2002US6458194 Excellent in transfer property, color and light fastness
10/01/2002CA2228370C Piperazino derivatives as neurokinin antagonists
10/01/2002CA2089769C Heterocyclic compounds and their preparation and use
09/2002
09/26/2002WO2002074780A1 Chemical compounds
09/26/2002WO2002074774A1 Cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitors
09/26/2002WO2002074773A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
09/26/2002WO2002074772A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
09/26/2002WO2002074754A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
09/26/2002WO2002074753A2 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi
09/26/2002WO2002074342A1 Remedies for arteriosclerosis
09/26/2002WO2002074312A1 Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors
09/26/2002WO2002074293A2 Methods for restoring cognitive function following systemic stress
09/26/2002WO2002074171A1 Fluorescent cobalamins and uses thereof
09/26/2002WO2002055517A3 4-(hetero)aryl substituted indolinones
09/26/2002WO2002040487A3 Benzodiazepine derivatives as gaba a receptor modulators
09/26/2002WO2002040484A3 Novel imidazole derivatives, production method thereof and use thereof
09/26/2002WO2002032872A8 Nitrogenous aromatic ring compounds
09/26/2002WO2000043375A3 Substituted aryl heterocyclic compounds
09/26/2002WO1997019953A8 New lh-rh antagonists with improved effectiveness
09/26/2002US20020137961 Use as skin lightening agents; 4-(1,4-Dioxaspiro(4.5)dec-8-yl)-1,3-benzenediol for example
09/26/2002US20020137946 1-((4-halo-3-sulfonamidophenyl)aminocarbonyl),2-carboxy -pyrrolidine intermediate of given formula
09/26/2002US20020137945 Synthesis of compounds useful in the manufacture of ketorolac
09/26/2002US20020137939 Novel guanidinobenzamides
09/26/2002US20020137932 Treating autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, and asthma
09/26/2002US20020137930 Reacting imidazotriazinones with sulphuric acid and the products obtained are then reacted with thionyl chloride and converted in situ by reacting with a secondary amine
09/26/2002US20020137925 Regioisomerically pure oxochlorins and methods of synthesis
09/26/2002US20020137924 Such as meso-formyl porphyrins, meso-acrylate porphyrins, purpurins and benzochlorins. In particular, tin ethyl etiopurpurin (SnET2) and the intermediates necessary for its production without chromatography
09/26/2002US20020137784 Guanidine derivatives
09/26/2002US20020137755 Tyrosine kinase inhibitors
09/26/2002US20020137739 Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents
09/26/2002US20020137735 Therapy of auto-immune disease by a photochemotherapeutical method
09/26/2002US20020137695 A nucleotide, e.g., 6-(beta-D-2-Deoxyribofuranosyl)-5-hydro-methyl-8H-pyrimido(4,5 -c)(1,2)pyridazin-7-one-5'-triphosphate, incorporated into a polynuceotide or an oligomucleotide; viricides; labels
09/26/2002DE10114565A1 Verbesserte Esterherstellung Improved ester production
09/26/2002CA2442717A1 Methods for restoring cognitive function following systemic stress
09/26/2002CA2441202A1 Chemical compounds
09/26/2002CA2440405A1 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi
09/26/2002CA2439528A1 Cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitors
09/26/2002CA2436911A1 Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors
09/25/2002EP1243580A1 Heterocyclic imino compounds and fungicides and insecticides for agricultural and horticultural use
09/25/2002EP1243575A2 Preparation of esters in the presence of onium salts
09/25/2002EP1243333A2 High surface microporous materials which are active in oxidation reactions. tiq-6 and metiq-6
09/25/2002EP1243271A1 Nasal drops containing fused pyridazine derivatives
09/25/2002EP1242851A1 Use of a composition in stereolithography
09/25/2002EP1242427A1 Novel piperidine and piperazine derivatives
09/25/2002EP1242425A2 N-(5,7-DIMETHOXY[1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YL) ARYLSULFONAMIDE COMPOUNDS AND THEIR USE AS HERBICIDES
09/25/2002EP1242424A2 Process for the preparation of pyrazolo[1,5-b]pyridazine derivatives
09/25/2002EP1242423A1 SUBSTITUTED 1,2,3-TRIAZOLO 1,5-a]QUINAZOLINES FOR ENHANCING COGNITION
09/25/2002EP1242422A1 Tricyclic dihydropyrimidine potassium channel openers
09/25/2002EP1242420A2 Agents and methods for the treatment of proliferative diseases
09/25/2002EP1242385A1 Cytokine, especially tnf-alpha, inhibitors
09/25/2002EP1242383A1 Aza compounds having neuronal activity
09/25/2002EP1242327A1 Pigmented vitreous material its precursor glass items coated therewith and method of its preparation
09/25/2002EP1181279A4 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof
09/25/2002EP0835258B1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues
09/25/2002CN1371412A Selectively light absorptive material, coating composition containing the same, and filter manufactured using the coating composition for color displays
09/25/2002CN1371377A Method for producing triethylene diamine, using ethylene diamine
09/25/2002CN1371374A Substituted heterocycle fused gamma-carbolines
09/24/2002US6455585 Have a higher analgesic activity, a lower toxicity and a longer effective time period than tramadol.